Sanjita Sasmal

Title: Sanjita Sasmal: Innovator in Pyridazine Derivatives and SMARCA2/4 Research

Introduction: Sanjita Sasmal, based in Hyderabad, Telangana, India, is an accomplished inventor known for her significant contributions to the field of pharmaceuticals. With a total of six patents to her name, she has established herself as a key figure in developing new therapeutic agents, particularly focusing on SMARCA2/4 degraders.

Latest Patents: One of her most notable inventions is the development of pyridazine derivatives, which are categorized as SMARCA2/4 degraders. This patent outlines the formula (I) for these compounds, highlighting their therapeutic potential in treating conditions reliant on SMARCA2/4 in mammals. Additionally, for these derivatives, the invention provides insights into their preparation and formulations as pharmaceutical compositions, including potential salts and stereoisomers. Another critical patent details a method for treating diseases with these SMARCA2/4 degraders, specifically targeting subjects likely to respond based on tumor-specific alterations. This invention includes methods to treat prostate cancer effectively, further emphasizing the clinical relevance of her work.

Career Highlights: Throughout her career, Sanjita has worked with some prestigious organizations, including Orion Corporation and Mitobridge, Inc. Her experience in these companies has equipped her with the expertise necessary to innovate and develop pharmaceutical advancements in her field.

Collaborations: Sanjita has collaborated with notable coworkers such as Susanta Samajdar and Chandrasekhar Abbineni. These collaborations have likely played a vital role in the research and development of her innovative pharmaceutical solutions, fostering a creative and productive research environment.

Conclusion: In summary, Sanjita Sasmal stands out as a prominent inventor, making significant strides in the pharmaceutical industry through her inventive work on pyridazine derivatives and SMARCA2/4 degraders. Her dedication to advancing treatment methodologies is evident in her patents and collaborative projects, marking her as a key contributor to innovation in medicine.